Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antiphospholipid antibodies syndrome]

P Disdier1, P J Weiller

  • 1Service de médecine interne, Hôpital de la Timone, Marseille.

La Revue Du Praticien
|October 22, 1998
PubMed
Summary

Antiphospholipid syndrome involves blood clots, pregnancy loss, and antiphospholipid antibodies like anticardiolipin. Current primary treatment for this condition is warfarin.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The practice of telemedicine by French internal medicine physicians in 2019].

La Revue de medecine interne·2021
Same author

La Revue de medecine interne·2020
Same author

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma.

Bone marrow transplantation·2017
Same author

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma.

Bone marrow transplantation·2017
Same author

The patient's CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide.

Bone marrow transplantation·2016
Same author

[E-cigarette use in university students and its relationship to cigarette smoking].

Revue des maladies respiratoires·2015

Area of Science:

  • Immunology
  • Hematology
  • Obstetrics

Context:

  • Antiphospholipid syndrome (APS) is an autoimmune disorder.
  • Characterized by recurrent thromboses and pregnancy morbidity.
  • Associated with specific antiphospholipid antibodies.

Purpose:

  • To define the key features and diagnostic markers of Antiphospholipid Syndrome.
  • To outline the primary clinical manifestations and complications.
  • To identify current therapeutic strategies.

Summary:

  • APS presents with thromboses, fetal losses, and antiphospholipid antibodies (e.g., lupus anticoagulant, anticardiolipin, anti-beta 2-glycoprotein 1).
  • Key clinical signs include recurrent thrombophlebitis, pulmonary embolism, arterial disease, fetal loss, livedo reticularis, and thrombocytopenia.
  • Warfarin is the established primary treatment for managing APS.

Impact:

  • Improved understanding of APS diagnosis and clinical spectrum.
  • Highlights the significance of antiphospholipid antibodies in disease pathogenesis.
  • Informs clinical management and treatment decisions for APS patients.

Related Experiment Videos